Documents | DEA.gov
Skip to main content
U.S. flag

An official website of the United States government

Here’s how you know

Dot gov

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Https

Secure .gov websites use HTTPS
A lock ( Lock A locked padlock ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

  • Who We Are
    • About
    • Mission
    • Leadership
    • History
    • Divisions
      • Domestic Divisions
      • Foreign Divisions
      • Operational Divisions
    • DEA Museum
    • Wall of Honor
    • Contact Us
      • Submit a Tip
      • Extortion Scam
      • Public Affairs
      • Social Media Directory
  • What We Do
    • Forensic Sciences
      • GUARDS
      • Forensic Sciences Policy
      • Forensic Science Organizations
      • Forensic Science Contact
    • Law Enforcement
      • DEA Office of Training
        • Office of Training Programs
      • El Paso Intelligence Center (EPIC)
      • Intelligence
      • Operations
        • Administrative Law Judges
        • DEA Asset Forfeiture
        • Domestic Cannabis Suppression / Eradication Program
        • HIDTA
        • OCDETF
    • Education and Prevention
      • Family Summit
      • Red Ribbon
      • Kiki and the History of Red Ribbon Week
      • Red Ribbon Toolkit - Resources For Your Community
      • DEA’s Family Summit
      • Operation Engage
      • Community Outreach
      • Just Think Twice
      • Campus Drug Prevention
      • Get Smart About Drugs
      • Operation Prevention
    • Drug Information
      • Drug Policy
      • Drug Scheduling
      • The Controlled Substances Act
    • News
      • Alerts
      • Press Releases
      • Most Wanted Fugitives
        • All Fugitives
      • Stories
      • Events
      • Speeches
      • Testimony
    • Campaigns
      • One Pill Can Kill
        • Senior Citizens
        • Partner Toolbox
        • Social Media Campaign
      • DEA National Prescription Drug Take Back Day
  • Careers
    • Special Agent
      • Special Agent FAQs
    • Diversion Investigator
      • Diversion Investigator Job Announcement
    • Intelligence Research Specialist
      • Intelligence Research Specialist Job Announcements
      • Intelligence Research Specialists FAQs
      • Schedule A Hiring Authority: Intelligence Research Specialist
    • Forensic Sciences Careers
    • Professional & Administrative Careers
    • Student & Entry Level Careers
    • Employment Eligibility
    • How to Apply
      • How To Claim Veterans' Preference
      • Priority Consideration
      • Benefits
      • Veterans and People With Disabilities
      • Operation Warfighter
  • Resources
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Data and Statistics
      • Domestic Arrests
      • Staffing and Budget
    • FOIA
      • About FOIA
      • Contact DEA FOIA
      • Make a Request
      • What Happens After Making a Request
      • Requester Categories
      • Fees Charged
      • Fee Waiver
      • FOIA FAQ
      • FOIA Logs and Reports
      • FOIA Library
      • Additional FOIA Links
      • FOIA Exemptions
      • What Are Exclusions?
      • Privacy Act
      • Privacy Act Exemptions
      • Privacy Impact Assessment and Management Information Systems
    • Publications
    • Media Galleries
    • Victim Witness Assistance Program
      • Victim Witness Assistance Program Resources
      • Human Trafficking Prevention

United States Drug Enforcement Administration

  • Get Updates
  • Scam Alert
  • Full Menu
  • English
  • Español

Main Menu

Explore DEA
  • Who We Are
    • About
    • Mission
    • Leadership
    • History
    • Divisions
    • DEA Museum
    • Wall of Honor
    • Contact Us
  • What We Do
    • Forensic Sciences
    • Law Enforcement
    • Education and Prevention
    • Drug Information
    • News
    • Campaigns
  • Careers
    • Special Agent
    • Diversion Investigator
    • Intelligence Research Specialist
    • Forensic Sciences Careers
    • Professional & Administrative Careers
    • Student & Entry Level Careers
    • Employment Eligibility
    • How to Apply
  • Resources
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Data and Statistics
    • FOIA
    • Publications
    • Media Galleries
    • Victim Witness Assistance Program
  • Submit A Tip

Documents

Advanced Search

Enter Keywords Below

Filter Results

Select To Narrow Search Results

Document Type

  • Testimony (88)
  • Microgram (49)
  • DEA Administrator Remarks (27)
  • Speech (21)
  • Announcements (3)
  • In the News (1)
  • Publication (141)

Publication Type

  • Intelligence (70)
  • Forensics: Quality Management System Documents (32)
  • Drug Prevention (22)
  • Forensics (10)
  • DEA Administrator (3)
  • Recruitment (1)

Drug Name

  • Narcotics (Opioids) (15)
  • Heroin (7)
  • Methamphetamine (6)
  • Cannabis (4)
  • Drugs of Concern (4)
  • Marijuana (4)
  • Xylazine (3)
  • Cocaine (2)
  • Fentanyl (2)
  • Designer Drugs (1)
  • Hallucinogen (1)
  • Spice/K2, Synthetic Marijuana (1)
  • Steroids (1)
  • Synthetic Opioids (1)

Topic

  • Forensics: Quality Management System Documents (30)
  • Forensic Sciences (8)
  • Family (1)
  • Self Help/Personal Growth (1)
Clear All Results
DOCUMENT

2015 Heroin Domestic Monitor Program

October 01, 2017
Publication
The Drug Enforcement Administration’s (DEA) Heroin Domestic Monitor Program (HDMP) is a retail-level heroin purchase program that provides data analysis about the geographic source of heroin, along with price, purity, adulterants, and diluents sold at the street-level in 27 U.S. cities. In 2015, a total of 823 qualified exhibits were...
October 01, 2017
DOCUMENT

Fake Rx in Indiana: Carfentanil and Fentanyl found in Purported Oxycodone Pills

August 01, 2017
Publication
A recent enforcement operation by the Drug Enforcement Administration’s (DEA) Indianapolis District Office (IDO) resulted in the seizure of 970 purported prescription pills that were various shades of blue and appeared to be oxycodone. Laboratory analysis subsequently revealed that the pills were counterfeit; the dark blue pills contained carfentanil and...
August 01, 2017
DOCUMENT

Methamphetamine Fatalities on the Rise in King County, Washington

August 01, 2017
Publication
The King County Medical Examiner’s Office (KCMEO) reported that deaths caused by drugs increased to their highest levels in 2016 in King County, Washington. Methamphetamine was responsible for 109 (30 percent) of the 360 drug deaths according to KCMEO data. DEA reporting indicates that the methamphetamine responsible for the overdose...
August 01, 2017
DOCUMENT

Colombian Cocaine Production Expansion Contributes to Rise in Supply in the United States

August 01, 2017
Publication
Changes in key international cocaine market indicators point to the highest U.S. cocaine supply levels since at least 2007. National data also show the most significant increase in domestic cocaine usage since at least 2009. Recent cocaine production and U.S. Transit Zone movement indicators have reached the highest levels ever...
August 01, 2017
DOCUMENT

The 2015 Heroin Signature Program Report

August 01, 2017
Publication
The Drug Enforcement Administration’s (DEA) Heroin Signature Program (HSP) analyzes several hundred wholesale-level heroin samples each year to identify the geographic area—Mexico, South America (SA), Southwest Asia (SWA), or Southeast Asia (SEA)—where the samples were manufactured.
August 01, 2017
DOCUMENT

Analysis of Overdose Deaths in Pennsylvania, 2016

July 01, 2017
Publication
The Commonwealth of Pennsylvania is in the midst of an unprecedented epidemic of drug abuse and drug-related overdose deaths impacting every corner of the state and all of its residents. In 2016, more than 4,600 Pennsylvanians died as a result of drug abuse, with thousands more affected by addiction, either...
July 01, 2017
DOCUMENT

Opiate Overdoses and Naloxone Administrations in New Orleans

July 01, 2017
Publication
Documenting the administration of naloxone in New Orleans, LA, is one way to determine the amount of heroin being abused in the city. Naloxone, sold under the name Narcan®, is a medication used to counter the effects of heroin and opioid overdoses. Naloxone is typically administered by first responders and...
July 01, 2017
DOCUMENT

BUL-153-17 Opiate Overdose Deaths Remain High in Seattle and King County

June 22, 2017
Publication
The King County Medical Examiner’s (KCME) Office reported that deaths caused by drugs increased to their highest levels in 2016 in both Seattle and King County, Washington. The majority (63 percent) of the 360 deaths were caused by opioids. The opioids responsible for the overdose deaths were opium derivatives such...
June 22, 2017
DOCUMENT

Opioid Overdose Deaths Remain High in Seattle and King County

June 01, 2017
Publication
The King County Medical Examiner’s (KCME) Office reported that deaths caused by drugs increased to their highest levels in 2016 in both Seattle and King County, Washington. The majority (63 percent) of the 360 deaths were caused by opioids. The opioids responsible for the overdose deaths were opium derivatives such...
June 01, 2017
DOCUMENT

The Opioid Threat in the Chicago Field Division

June 01, 2017
Publication
All available indicators—including investigative intelligence, case initiations, seizure and arrest data, abuse indicators, and anecdotal information—indicate that opioids present the greatest illegal drug threat to the Drug Enforcement Administration (DEA) Chicago Field Division (CFD), which encompasses the states of Indiana, Minnesota, North Dakota, Wisconsin, and the Northern and Central U.S...
June 01, 2017
Showing 111 - 120 of 141 results

Pagination

  • First page «
  • Previous page ‹
  • Page 11
  • Current page 12
  • Page 13
  • Page 14
  • Next page ›
  • Last page »
  • Who We Are
    • About
    • Domestic Divisions
    • Foreign Offices
    • Contact Us
    • DEA Museum
  • What We Do
    • Forensic Sciences
    • Law Enforcement
    • Drug Prevention
    • Diversion Control Division
    • News
  • Careers
    • Special Agent
    • Diversion Investigator
    • Forensic Sciences
    • Intelligence Research Specialist
    • How to Apply
  • Resources
    • Drug Information
    • Employee Assistance Program
    • FOIA
    • Publications
    • Media Galleries
    • VWAP
  • Doing Business
    with the DEA
    • Overview
    • Current Vendors
    • Prospective Vendors
    • Security Clauses
    • Security Forms
    • Small Business Program
    • Vendor Engagement Request
  • Policies
    • Accessibility & Policy
    • Legal Policies & Disclaimers
    • No FEAR Act
    • Privacy Policy
    • U.S. Department of Justice EEO Policy
    • USA.gov
    • Whistleblower Protection
    • Your Rights as a Federal Employee

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook X LinkedIn Instagram

DEA Contact Center

(202) 307-1000
Contact the Webmaster